Pakistan makes most of #MedSafetyWeek with launch of safety app

Around the world / 01 February 2021

Pakistan’s ambitious pharmacovigilance authorities made the most of the recent #MedSafetyWeek, leveraging that campaign to successfully launch the Med Safety App in the country.


Pakistan’s apex regulatory body for therapeutic goods, the Drug Regulatory Authority of Pakistan (DRAP), launched the Med Safety App during #MedSafetyWeek 2020. This app – developed for Pakistan in collaboration with the UK’s Medicines and Healthcare products Regulatory Authority (MHRA), UMC, and the World Health Organization (WHO) – now makes it easy for anyone to report adverse drug reactions (ADRs) through their mobile devices. This is yet another step towards strengthening pharmacovigilance in Pakistan. It builds upon the comprehensive national pharmacovigilance network DRAP has recently established, comprising the centrally operated Pakistan National Pharmacovigilance Centre (PNPC) in Islamabad integrated with regional pharmacovigilance centres.

“PNPC, Division of Pharmacy Services is very thankful to MHRA, UMC, and WHO for their technical and financial support in developing this mobile application,” said Dr. Abdur Rashid, Head of PNPC and Director of Pharmacy Services at DRAP.

“The Med Safety App is simple, easy to use, and very convenient for uploading information about adverse reactions. It is paperless, hence environmentally friendly, and urges swift corrective measures on identified safety issues.”

Screenshots from Pakistan's Med Safety App

Screenshots from Pakistan's Med Safety App

This was the first time Pakistan has participated in #MedSafetyWeek, and our campaign was carried out mainly through social media, covering dissemination of information on the necessity of reporting ADRs, the Med Safety App and its use, and ways to easily access related information from the app. Throughout the week of the campaign, we used print and electronic media, displayed physical posters and other materials, and we used our official Twitter and Facebook accounts to post banners. We also encouraged our employees to share banners about the Med Safety App through their personal social media accounts. The response we received from most colleagues, friends, and acquaintances was appreciative and encouraging, and everyone was eager to reshare the animations which conveyed serious messages in an interesting, slightly amusing, and fun way. 

From DRAP’s perspective, #MedSafetyWeek was an opportunity for boosting awareness of the Med Safety App in Pakistan. The messages and material provided by UMC were appealing and attractive and they developed interest and curiosity in the audience to seek more information.

There is always a pressing need to reach out to patients and healthcare professionals in Pakistan for a true picture of the ADRs being experienced.

“Everyday tens of thousands of patients suffer from unnoticed harms or adverse drug reactions (ADRs) throughout the world. These harms increase hospital admissions and, in some cases, might result in mortality and morbidity,” said DRAP CEO, Asim Rauf.

But #MedSafetyWeek and the awareness campaign about ADR reporting through the Med Safety App made it possible to sensitize ordinary people to these issues.

“Patient safety is the ultimate objective of a regulator and DRAP has implemented a framework of clear policies. This app will help us with reporting of ADRs so that we become more vigilant about the harms posed by various therapeutic goods,” Rauf said.

“I urge all healthcare providers to give the highest consideration to medication safety by reporting any suspected ADR to PNPC. This will help to provide more information about therapeutic goods, which will ultimately help to make them safer and prevent the occurrence of that harm in other patients.”

Tags: Pakistan, #MedSafetyWeek, MedSafetyApp, campaigns

Aqsa Hashmi
Assistant Director (Division of Pharmacy Services), Drug Regulatory Authority of Pakistan

You may also like


Egypt’s bold #MedSafetyWeek 2020 agenda sets example for 2021

#MedSafetyWeek 2020 was the most successful ever. One of the broadest and most active agendas took shape in Egypt, setting a great example for future events.

Around the world / 14 January 2021

COFEPRIS boosts ability to receive and analyse adverse drug reaction reports

The move to VigiFlow has proven to be a boon for pharmacovigilance in Mexico, improving report management practices in Latin America’s second biggest medicines market.

Around the world / 17 June 2020

PROFORMA project promoting medicines safety in Africa

The PROFORMA project makes strides in several African countries, promoting the networks and capacities needed to help safety systems keep pace with improving access to medicines.

Around the world / 17 June 2020

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more